July 20, 2026 - 22:45

Swedish electric vehicle maker Polestar has decided not to challenge a U.S. government order that effectively bans the sale of its cars in the American market. According to a recent report, the company will formally exit the United States after extensive talks with the U.S. Department of Commerce failed to produce a compromise.
The ban stems from concerns over the use of Chinese-developed technology in Polestar vehicles. The automaker is owned by Volvo Car AB and Zhejiang Geely Holding Group, and its cars rely heavily on software and components sourced from China. U.S. regulators have grown increasingly wary of such dependencies, citing national security risks. Rather than pursuing a lengthy legal battle, Polestar has chosen to accept the ruling and redirect its focus to other global markets.
This decision marks a significant shift for the brand, which had positioned the U.S. as a key growth region. Polestar had been selling its electric sedans and SUVs in America since 2020, building a small but loyal customer base. Now, existing owners will still receive service and support, but no new vehicles will be imported for sale. The company has not yet announced whether it will attempt to redesign its supply chain to comply with U.S. rules in the future.
For now, Polestar is concentrating on expanding in Europe and Asia, where regulatory hurdles are less severe. The move underscores the growing geopolitical tension between Washington and Beijing, and how it continues to reshape the global auto industry.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...